The findings and conclusions in this paper are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME)
Version of Record online: 25 JUL 2013
© 2013 American Association of Blood Banks
Volume 54, Issue 4, pages 972–981, April 2014
How to Cite
Vichinsky, E., Neumayr, L., Trimble, S., Giardina, P. J., Cohen, A. R., Coates, T., Boudreaux, J., Neufeld, E. J., Kenney, K., Grant, A., Thompson, A. A. and CDC Thalassemia Investigators (2014), Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME). Transfusion, 54: 972–981. doi: 10.1111/trf.12348
This study was supported by the Centers for Disease Control and Prevention (CDC): 5U01DD000310-05 to Children's Hospital & Research Center Oakland, U01-DD00306 to Children's Hospital Philadelphia, U01-DD00309 to Children's Hospital Los Angeles, U01-DD000308-05 to Boston Children's Hospital, U01-DD0003075 to Ann & Robert H. Lurie Children's Hospital of Chicago, and U01-DD000311-05 to Weill Medical College of Cornell University. In addition, Boston Children's Hospital was supported by NCRR Grant M01-RR02172.
- Issue online: 11 APR 2014
- Version of Record online: 25 JUL 2013
- Manuscript Accepted: 1 JUN 2013
- Manuscript Revised: 6 MAY 2013
- Manuscript Received: 13 SEP 2012
- Centers for Disease Control and Prevention (CDC). Grant Numbers: 5U01DD000310-05, U01-DD00306, U01-DD00309, U01-DD000308-05, U01-DD0003075, U01-DD000311-05
- NCRR. Grant Number: M01-RR02172
Appendix S1. Site and staff information.
Appendix S2. Procedures for laboratory testing of infections by the CDC.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.